Physician profile
Rita Tenenbaum
NPI 1639263148
$2,429.04
in general payments reported to CMS, 2019-2025
23 companies · $392 in 2025
The $392 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $265 · 2021: $391 · 2022: $498 · 2023: $494 · 2024: $92.66 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $979.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $594.43 | 2019-2025 | |
| Glaxosmithkline, LLC. | $276.61 | 2019-2025 | Bexsero, Penmenvy |
| Corium, LLC | $265.80 | 2022-2025 | Azstarys |
| Sanofi Pasteur INC. | $234.72 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $219.45 | 2019-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Sanofi-Aventis U.S. LLC | $163.68 | 2023-2025 | |
| Cranial Technologies, INC | $132.41 | 2019-2025 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $98.53 | 2020-2021 | |
| Sobi, INC | $87.29 | 2022-2023 | |
| Arbor Pharmaceuticals, INC. | $65.01 | 2019-2020 | |
| Genzyme Corporation | $47.12 | 2023 | |
| Genentech USA, INC. | $31.37 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $28.57 | 2025 | Zoryve |
| Kaleo, INC. | $26.60 | 2022 | |
| Alk-Abello, INC | $26.00 | 2025 | Neffy |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $24.29 | 2025 | Ycanth |
| Organon LLC | $20.68 | 2025 | Vtama |
| Smith+Nephew, INC. | $19.68 | 2019 | |
| Lnhc, INC | $18.16 | 2025 | Zelsuvmi |
| Shire North American Group INC | $15.45 | 2019 | |
| Seqirus USA INC | $15.28 | 2025 | Flucelvax |
| Mission Pharmacal Company | $13.59 | 2019 | |
| Prugen, INC. Pharmaceuticals | $4.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Tenenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.